Allergan Seeks To Block Pfizer Unit's Generic Dry-Eye Drug
Allergan Inc. has hit InnoPharma Inc. with a patent-infringement lawsuit in Delaware federal court seeking to block the Pfizer Inc.-owned drugmaker from releasing a generic version of Allergan's chronic dry-eye drug...To view the full article, register now.
Already a subscriber? Click here to view full article